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ABSTRACT
Fibroblast growth factor 9 (FGF9) is an autocrine/
paracrine growth factor that plays vital roles in
many physiologic processes including embryonic
development. Aberrant expression of FGF9 causes
human diseases and thus it highlights the import-
ance of controlling FGF9 expression; however, the
mechanism responsible for regulation of FGF9 ex-
pression is largely unknown. Here, we show the
crucial role of an AU-rich element (ARE) in FGF9
30-untranslated region (UTR) on controlling FGF9 ex-
pression. Our data demonstrated that AUF1 binds
to this ARE to regulate FGF9 mRNA stability.
Overexpression of each isoform of AUF1 (p37, p40,
p42 and p45) showed that only the p42 isoform
reduced the steady-state FGF9 mRNA. Also,
knockdown of p42
AUF1 prolonged the half-life of
FGF9 mRNA. The induction of FGF9 mRNA in pros-
taglandin (PG) E2-treated human endometrial
stromal cells was accompanied with declined cyto-
plasmic AUF1. Nevertheless, ablation of AUF1 led to
sustained elevation of FGF9 expression in these
cells. Our study demonstrated that p42
AUF1 regu-
lates both steady-state and PGE2-induced FGF9
mRNA stability through ARE-mediated mRNA deg-
radation. Since almost half of the FGF family
members are ARE-containing genes, our findings
also suggest that ARE-mediated mRNA decay is a
common pathway to control FGFs expression, and it
represents a novel RNA regulon to coordinate FGFs
homeostasis in various physiological conditions.
INTRODUCTION
The mammalian ﬁbroblast growth factor (FGF) family
includes 18 distinct members and are grouped into six
subfamilies based on the differences in sequence
homology and phylogeny [review see (1)]. Many of these
FGFs are expressed abundantly in a speciﬁc spatial and
temporal pattern and considered to play substantial roles
in development (2), angiogenesis (3), hematopoiesis (4)
and tumorigenesis (5). Human ﬁbroblast growth factor 9
(FGF9; MIN# 600921) shares >93% sequence identity
with Xenopus, mice and rats (6,7), suggesting that FGF9
is important and may have similar functions across
species. Previous studies suggested that FGF9 functions
as an autocrine/paracrine growth factor for neuron cells
(8), ﬁbroblasts (9) and endometrial stromal cells (10), and
as an oncogene for NIH3T3 ﬁbroblast cells (11).
FGF9 mRNA is ubiquitously expressed in the embryo
but is restricted to kidney, brain and uterus in the adult
(10–12). Furthermore, abnormal expression of FGF9 is
involved in several human diseases, including cancer
(13,14), endometriosis (15), neuron degeneration (16),
male-to-female sex reversal (17) and male infertility (18).
Nevertheless, upon stimulation by factors like prostaglan-
din (PG) E2 (19), estrogen (10), androgen (20) and retinoic
acid (21), the mRNA of FGF9 is upregulated but rapidly
returns to basal levels. These studies implied that the ex-
pression of FGF9 needs to be strictly controlled. While the
functions of FGF9 in physiological and pathological
processes are well studied, mechanisms that control
steady-state and stimuli-induced FGF9 mRNA levels to
maintain FGF9 homeostasis remain largely unknown.
Regulation of the rate of mRNA decay is an important
mechanism to control gene expression at the post-
transcriptional level (22). The interaction between cis-
acting elements in the transcripts and sequence-speciﬁc
RNA-binding proteins permits precise control of the
mRNA level and, subsequently, the protein level (23).
Adenylate/uridylate-rich elements (AREs) are regulatory
elements present in the 30-untranslated region (UTR) of
certain mRNAs that have been implicated in post-
transcriptional gene regulation by mediating rapid degrad-
ation of target mRNA (24,25). AREs are generally found
in transcripts that need to be precisely controlled, such as
genes that function as growth factors, proto-oncogenes
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have been identiﬁed (28) to interact with mRNA contain-
ing AREs. Most of these proteins, such as the AU-rich
element-binding protein 1 (AUF1) family (29), the
tristetraprolin (TTP) family (30) and the KH-type
splicing regulatory protein (KSRP) (31) reduce the target
mRNA level. In contrast, factors like human antigen R
(HuR) positively regulate target gene expression (32).
We previously reported that a microsatellite motif in the
30-UTR of the FGF9 gene is important for controlling the
mRNA stability of FGF9 (17). The work demonstrated a
new post-transcriptional regulation of FGF9 expression
and suggested the expression of FGF9 may be controlled
by a network that involves multiple layers of regulations.
In this study, we set out to investigate other novel mech-
anisms responsible for the tight regulation of FGF9
mRNA stability.
MATERIALS AND METHODS
Cell culture
A human embryonic kidney cell line HEK293 expressing
endogenous FGF9 was grown in minimum essential
medium (MEM) (Gibco, Carlsbad, CA, USA) with 10%
heat-inactivated horse serum and 1.0mM sodium
pyruvate. Stromal cells were cultured in DMEM/F12
with 10% fetal bovine serum (FBS). In both cases,
media were supplemented with 100U/ml penicillin and
100mg/ml streptomycin (Invitrogen, Carlsbad, CA,
USA). Cells were routinely maintained at 37 Ci na
humidiﬁed 5% CO2 incubator. For PGE2 treatment
(Cayman Chemical, Ann Arbor, MI, USA), phenol
red-free DMEM/F12 medium was supplemented with
1% charcoal-stripped FBS and 1mM PGE2. Cells
infected by shAUF1 and null virus were exposed to
1mM PGE2 for the indicated durations. In parallel, the
same amount of ethanol was used as control.
Plasmids
The entire FGF9 30-UTR sequence was ampliﬁed using
forward primer (FGF9 30-FUTR-F: 50-GCTCTAGA
GCGGACAAAGACAGTTTCTTCACT-30) and reverse
primer (FGF9 30-FUTR-R1: 50-GCTCTAGAGCTTTG
GAATTTCTATAAATAAATTTAAC-30) anchored with
XbaI restriction enzyme cutting sites. These XbaI poly-
merase chain reaction (PCR) products were ultimately
subcloned into the XbaI site of the pGL3-promoter
(pGL3-p) vector containing a SV40 promoter upstream
of the ﬁreﬂy luciferase gene (Promega, Madison, WI,
USA). The deletion and mutation constructs were
generated by the same strategy with different reverse
primers. FGF9 30-UTR 549R (50-GCTCTAGACTAAG
AGGTCTTTGCTTTAAG-30) and FGF9 30-FUTR-mut-
R1 (50-GCTCTAGAGCTTTGGAATTTCTATCCCTCC
CTTTAAC-30) were used for the delARE and mutARE
constructs, respectively. All constructs were conﬁrmed by
direct sequencing.
For AUF1 overexpression, the cDNA of AUF1 was
ampliﬁed with AUF1CDS-1 (50-TTTTTAAGCTTTGCT
GCTAGTTTCGGTTCG) and AUF1CDS-2 (CCCGCTC
GAGGTATGGTTTGTAGCTATTTTG) primers
anchored with restriction enzyme cutting sites HindIII
and XhoI (indicated by underline) on each 50-end, respect-
ively. The PCR products were digested by HindIII and
XhoI enzymes and cloned into pcDNA3.1/Myc_His(+)A
vector (Invitrogen).
Transient transfection and luciferase reporter assay
HEK293 cells were seeded on each well of a 24-well tissue
culture plate (2.5 10
5cells/well) (TPP AG, Trasadingen,
Switzerland) and transfected with each plasmid construct
(0.5mg) plus plasmids carrying renilla luciferase as an
internal control. The transfection was carried out with
Lipofectamine 2000 (Invitrogen) according to the manu-
facturer’s instructions. Cells were incubated for 24h and
harvested by adding 100ml of reporter lysis buffer
(Luciferase Assay System; Promega). The activity of
luciferase was measured using a luminometer (Lumat LB
9507; EG&G Berthold, Bad Wildbad, Germany). Fireﬂy
luminescence was normalized to the protein concentra-
tion. Results are presented relative to normalized lumines-
cence driven from pGL3-promoter and reported as
relative luciferase units (RLU). All experiments were
done in triplicate and independently performed at least
three times.
mRNA isolation and half-life measurement
Total RNA from cells was isolated with the RNeasy mini
kit (Qiagen, Hilden, Germany). For RNA half-life meas-
urements of luciferase mRNA, HEK293 cells were trans-
fected with 2.5mg plasmid/10
6 cells in 6-well plates using
Lipofectamine 2000. Twelve hours later, the cells were
treated with 5mg/ml actinomycin D (Act D) (Sigma, St
Louis, MO, USA). RNA was extracted from cells
treated with Act D at 0, 2, 4, 6 and 8h for RNA half-
life measurement. As for FGF9 mRNA half-life measure-
ment, HEK293 cells were transfected with 40nM siRNA/
10
6 cells in 6-well plates using Lipofectamine 2000. Act D
was added and RNA was isolated at 0, 10, 20, 30, 60 and
120min after treatment. Complementary DNA was
synthesized from 2mg of DNase-treated total RNA using
random primers and an ABI RT kit (Apply Biosystems,
Forster city, CA, USA).
Real-time PCR measurements were carried out with
the Applied Biosystem GeneAmp 7900. This assay was
performed with 40ng of RNA equivalent cDNA in tripli-
cate on an ABI 7900HT Sequence Detection System
and analyzed with SDS2.1 software (Apply Biosystems).
TaqMan formulations were used and modiﬁed by
validating the efﬁciency between target and reference
genes according to the manufacturer’s protocols (Apply
Biosystems). Luciferase TaqMan assays were per-
formed with the primer set pGL3-Luc-1512F (50-GC
GTTATTTATCGGAGTTGCAGTTG-30)/pGL3-Luc-
1512R (50-CATACTGTTGAGCAATTCACGTTCA-30)
and detected with pGL3-Luc-1512-Probe (50-(FAM) CC
GCGAACGACATTT (TAMRA)-30) from the Assays-by-
Design
SM service (Apply Biosystems). FGF9 TaqMan
assays were performed with primer set (HS00181829-ml
FGF9). Ribosomal 18s (4319413E) (Apply Biosystems)
8062 Nucleic Acids Research, 2010,Vol.38, No. 22was used as endogenous control. The comparative CT
method was used to calculate the relative amount of
each sample according to the previous description.
Finally, the mRNA half-life was determined by linear re-
gression analysis.
UV crosslink and biotin pull-down assay
RNA–protein-binding reactions were performed using
3–5mg of cytoplasmic extract, 5mg of recombinant
AUF1 (p45 isoform) purchased from USBiological
(Swampscott, MA, USA), 10ng biotin-labeled RNA and
2mg tRNA, in a ﬁnal volume of 20ml using Binding Buffer
A [20mM HEPES-KOH at pH 7.5, 2.5mM magnesium
chloride (MgCl2), 100mM potassium chloride (KCl), 20%
glycerol, 0.5mM dithiothreitol and protease inhibitor
tablets]. Heparin was added at 0.25mg/ml. Addition of
heparin up to 0.75mg/ml did not have any signiﬁcant in-
ﬂuence on the pattern of UV cross-linking. Reaction
mixtures were incubated for 1h at 37 C and UV irradiated
at 254nm for 20min (Stratagene, La JoUa, CA, USA) on
ice. The samples were analyzed by 10% SDS–PAGE and
detected by western analysis.
For biotin pull-down analysis, 200mg of whole-cell
lysates were incubated with 2mg puriﬁed biotinylated
riboprobes (FGF9 ARE: Biotin-AAAUUUAUUUAUA;
FGF9 mutant ARE: Biotin-AAAGGGAGGGAUA;
Dharmacon Research) for 1h at 25 C. Complexes were
isolated with paramagnetic streptavidin-conjugated
Dynabeads (Invitrogen), the unbound proteins were
removed, and after extensive washes with the binding
buffer, the proteins were step-eluted with protein sample
buffer. The eluted proteins were then analyzed by western
blot analysis.
Western blot analysis
Whole-cell lysates were obtained by RIPA lysis buffer
[50mM KCl, 5% (v/v) glycerol, 0.1% (v/v) Nonidet
P-40, 1mM MgCl2, 1mM dithiothreitol, 10mM Tris/
HCl pH 8.0]. Nucleus and cytoplasmic fraction were
isolated by NE-PER kit (Thermo, Waltham, MA, USA).
Protein concentration was determined by the Bradford
assay (Bio-rad, Hercules, CA, USA). After protein quan-
tiﬁcation, equal amounts of whole-cell lysates were boiled
in 4% sodium dodecyl sulfate (SDS) sample buffer
(250mM Tris–HCl, 20% 2-mercaptoethanol, 8% SDS,
40% glycerol and 0.02% bromophenol blue) and sub-
jected to SDS-PAGE separation. Proteins were
transferred onto polyvinylidene diﬂuoride membrane
(Amersham, Buckinghamshire, UK) and detected by an
enhanced chemiluminescence (ECL) kit (Amersham).
Endogenous AUF1 was detected by polyclonal rabbit
anti-mouse AUF1 antiserum (Upstate Biotechnology,
Charlottesville, VA, USA) at 1:4000 dilutions. Various
recombinant AUF1 isoforms were detected by rabbit
monoclonal anti-myc antibody at 1:2000 dilutions.
a-Tubulin was used as an internal control and detected
by rabbit monoclonal anti-a-tubulin antibody (Cell
Signaling Technologies, Beverly, MA, USA) at 1:2000 di-
lutions. Lamin A/C was used as loading control for
nucleus fraction and detected by mouse monoclonal
anti-lamin A/C antibody at 1:200 dilutions. (Santa Cruz
Biotech, Santa Cruz, CA, USA).
RNA interference
Small interfering RNAs (siRNA) targeting AUF1 and
scrambled control duplexes (Invitrogen) were transfected
into HEK293 cells with Lipofectamine 2000 (Invitrogen).
After 48h, total protein was isolated and analyzed by
western blot analysis. The knockdown efﬁciency was
calculated by normalizing to the signal intensity ﬁrst to
a-tubulin, and then divided by the value of scramble
control. For knockdown of AUF1 in stromal cells,
plasmids encoding shRNA that targeted all four AUF1
isoforms were transfected into 293T cells to generate
shAUF1 lentivirus. Plasmid without any shRNA (Null)
was used as a mock control in this experiment. The
lentiviral shRNA clones were from the National RNAi
Core Facility of Academic Sinica, Taiwan. Stromal cells
were infected with Null (pLK0.1) lentivirus, or AUF1
shRNA lentivirus.
Computational analysis of FGF9 30-UTR sequences
Sequences of FGF9 from the species Homo sapiens
(Human; NM_002010), Canis lupus familiaris (dog;
CF406880), Bos taurus (cow; DT899064.1), Sus scrofa
(swine; EW180881), Taeniopygia guttata (bird;
EH120653), Mus musculus (mouse; AA623627) and
Rattus norvegicus (rat; DV717281) were downloaded
from NCB1 CoreNucleotide and aligned with a multiple
sequence alignment program (http://searchlauncher.bcm
.tmc.edu/ multi-align/multi-align.html). Images of multiple
sequence alignment were output by BOXSHADE
(http://www.ch.embnet.org/software /BOX_form.html).
In addition, conserved cis-elements of FGF9 30-UTR
were screened by UTRdb (33) and UTRscan (34).
Statistical analysis
All the data sets were analyzed using GraphPad Prism 4.0
(GraphPad Software, Inc., San Diego, CA, USA) and pre-
sented as mean±SEM. Results were further analyzed
using one-way analysis of variance (ANOVA), and
post-test was processed using Tukey’s multiple compari-
son tests or the Student’s t-test.
RESULTS
The 30-UTR of FGF9 mRNA contains AU-rich elements
To identify potential factors that regulate FGF9 gene ex-
pression post-transcriptionally, we used bioinformatic
tools to search for putative regulatory elements in the
human FGF9 30-UTR. Beside the (GA)n and (TG)n micro-
satellite motifs we previously reported (17), an ARE
located at 593–601bp downstream of the stop codon
was identiﬁed (Figure 1A). Similar ARE motifs were
also identiﬁed in FGF9 of mouse, rat, cow, dog, swine
and distantly related vertebrate, bird. When these ARE
sequences were aligned with that found in the human,
the result showed 79% and 100% identities in the
AU-rich region and the core nonamer, respectively
Nucleic Acids Research, 2010,Vol.38, No. 22 8063(Figure 1B). These results demonstrated that the ARE in
the 30-UTR of human FGF9 is evolutionarily conserved
and suggested that it may play a functional role in
controlling the level of FGF9 mRNA.
ARE is a destabilization element
To functionally characterize the effects of FGF9 30-UTR
ARE on regulating FGF9 expression, sequences contain-
ing full-length FGF9 30-UTR (FGF930-UTR), FGF9
30-UTR with ARE deleted (delARE) and full length with
site-directed mutated ARE (mutARE) were cloned into
the 30-UTR of a ﬁreﬂy luciferase reporter construct
driven by an SV40 promoter (Figure 2A). Results from
the reporter assays showed that the luciferase activities of
delARE and mutARE constructs were increased  1.8-
(P<0.001) and 2-fold (P<0.001), respectively,
compared with the construct having full-length FGF9
30-UTR (Figure 2B). This result indicates that the ARE
is a functional cis-element of FGF9 mRNA and its
presence may cause mRNA degradation.
Next, we tested whether ARE affects the mRNA stabil-
ity by transfecting FGF930-UTR, delARE and mutARE
constructs into HEK293 cells and treating them with
5mg/ml actinomycin D to inhibit nascent RNA transcrip-
tion. After quantiﬁcation by reverse transcription real-
time PCR (RT-qPCR), the half-life of each fusion
mRNA was determined by linear regression analysis.
Our data showed that the fusion mRNA with full-length
Figure 2. FGF9 ARE decreases gene expression in HEK293 cells.
(A) Diagrams showing the ﬁreﬂy luciferase reporter gene construct
(top diagram), full-length FGF9 30-UTR cloned into the 30-end of the
ﬁreﬂy luciferase reporter gene (second diagram), and constructs con-
taining site-direct mutation of ARE (mutARE) (third diagram) and
deletion of ARE (delARE) (fourth diagram). Empty and gray squares
represent TG and GA dinucleotide repeats, respectively. The black
square represents ARE motif. (B) Reporter gene activity shown as
relative luciferase activity (fold) normalized to FGF9 30-UTR.
(C) Effect of FGF9 ARE on mRNA stability detected by real-time
RT-qPCR. FGF9 30-UTR (ﬁlled square), delARE (Filled triangle) or
mutARE (ﬁlled inverted triangle) was transfected into HEK293 cells,
which were treated with Act D (5mg/ml) to inhibit transcription of the
luciferase reporter gene. Results are normalized to time zero for each
construct. All data are shown as mean±SEM of 4–6 independent ex-
periments. *P<0.05; ***P<0.001.
Figure 1. Sequence features of the human FGF9 30-UTR. (A) The
sequence corresponding to the 30-UTR of FGF9 is depicted. The
initial TGA nucleotide sequence ( 3t o 1) corresponds to the trans-
lation stop codon. The GA and TG microsatellite motifs are marked in
italic type. The ARE sequence (ATTTATTTA) is marked in bold and
the underlines mark the poly-A signals (AATAAA). (B) Cross-species
alignment of mouse, rat, human, cow, dog, swine and bird showed an
overall 79% identity in the AU-rich element region.
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6.98±0.10h (Figure 2C). In contrast, fusion mRNAs
with either deleted or mutated FGF9 ARE signiﬁcantly
prolong the mRNA stability to 9.94±0.13 (P<0.05) or
16.34±0.05h (P<0.05; Figure 2C). These results
demonstrated that FGF9 ARE is required to reduce the
half-life of fusion transcripts.
AUF1 speciﬁcally binds to FGF9 ARE
To determine whether FGF9 ARE can form protein–RNA
complex, we performed UV cross-linking assays and
detected three major bands corresponding to molecular
masses of  37, 45 and 55kDa in whole-cell extracts
(Figure 3A). Competition assays showed that these three
interacting complexes were quenched with speciﬁc cold
probes (Figure 3A, left), but not with non-speciﬁc ones
(Figure 3A, right). These data indicated the proteins are
speciﬁcally binding to FGF9 ARE.
Since the molecular weights of the proteins binding to
FGF9 ARE are similar to those of AUF1, we set out ex-
periments to test whether AUF1 is the binding protein of
FGF9 ARE. Commercially puriﬁed AUF1 protein was
Figure 3. AUF1 speciﬁcally binds to FGF9 30-UTR ARE. (A) UV cross-linking to biotin-labeled riboprobe from whole-cell lysate of HEK293 cells
showed three protein–RNA complexes. Competition assays were performed by adding extra non-biotin-label (cold) riboprobe as competitor with
labeled probe. Left panel, speciﬁc cold probe; right panel, non-speciﬁc cold probe. (B) Dose-dependence of proteins in cell lysate (left panel) and
AUF1 (right panel) binding to FGF9 ARE. (C) UV cross-linking in cell lysate (left panel) and AUF1 protein (right panel) showing linkage to
proteins in the wild-type FGF9 ARE but not to the mutant ARE.
Nucleic Acids Research, 2010,Vol.38, No. 22 8065used in parallel with cell lysate to interact with FGF9 RNA
probe. The AUF1–FGF9 complex showed a migration
rate similar to the 45-kDa complex protein and
the protein–RNA binding seems to be dose dependent
(Figure 3B). Furthermore, using the mutant probe with
a sequence change from AUUUAUUUA to AGGGAG
GGA, the protein–RNA complexes located at 37–45kDa
disappeared, while a new complex with molecular mass of
 60kDa was shown (Figure 3C, left). Interestingly, the
AUF1–FGF9 complex showed a migration rate similar
to the 45-kDa complex protein and the protein–RNA
binding seems to be abolished when the mutant probe
was applied in the reaction (Figure 3B, right). Taken
together, these data demonstrated that AUF1 speciﬁcally
binds to FGF9 ARE and the molecular weight of AUF1–
protein complex is  45kDa.
AUF1 knockdown increases FGF9 mRNA level
To determine the effect of AUF1 on regulation of FGF9
mRNA, synthetic siRNAs were used to knockdown the
endogenous AUF1 in HEK293 cells. Among three
exon-speciﬁc siRNAs tested, the use of AUF1 exon
1-speciﬁc siRNA resulted in the best knockdown effect
(Supplementary Figure S1) and was applied in the experi-
ments thereafter. As shown in Figure 4A, compare to the
scramble (SC) and AUF1-speciﬁc siRNA controls (AC),
the AUF1 exon 1-speciﬁc siRNA commonly knockdown
all 4 AUF1 isoforms. Knocking down AUF1 showed a
2.5-fold increase in luciferase reporter activity in the
presence of FGF9 ARE (P<0.01; Figure 4B). In
contrast, the mutARE reporter construct was not
affected by AUF1 knockdown indicating the speciﬁcity
of the AUF1 effect (Figure 4B). Furthermore, knocking
down AUF1 also signiﬁcantly increased endogenous
FGF9 mRNA level to almost 2-fold (P<0.01;
Figure 4C). Using RNA stability assays, our data
demonstrated that the half-life of endogenous FGF9
mRNA indeed extended from 19.5 to 60.2min in
AUF1-depleted cells (P<0.001; Figure 4D). Collectively,
these data strongly suggest that AUF1 is involved in the
destabilization of human FGF9 transcripts.
p42
AUF1 overexpression decreases FGF9 mRNA level
Finally, we determined whether overexpression of AUF1
has the opposite effect on FGF9 mRNA stability. A biotin
pull-down assay was carried out to test the interaction
between FGF9 ARE and AUF1. As expected, AUF1
was speciﬁcally interacted with FGF9 ARE sequence, es-
pecially the p42 isoform. Moreover, mutation of the core
sequence from U to G resulted in a decrease of the binding
afﬁnity to <20% (Figure 5A). To study the isoform-
speciﬁc interaction between FGF9 ARE and AUF1
Figure 4. AUF1 controls FGF9 mRNA stability. (A) Western blots showing AUF1-speciﬁc siRNA, but not the scramble control (SC) or
AUF1-speciﬁc siRNA control (AC), knocks down AUF1 protein. Mock is HEK293 cells treated with transfecting reagent only and a-tubulin
was used as a control. (B) Luciferase reporter activities in empty vector (pGL3-P), full length (FGF9 30-UTR), and mutant (mutARE) after
AUF1 or scramble siRNA knockdown were shown. (C) Endogenous FGF9 mRNA levels in HEK293 cells following AUF1 or scramble siRNA
knockdown. (D) Real-time RT-qPCR measurements showing the half-life of endogenous FGF9 mRNA with or without siRNA knockdown. Results
are normalized to time zero for each construct. All data are shown as mean±SEM of 4–6 independent experiments. **P<0.01; ***P<0.001.
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overexpressed in HEK293 cells. The expression of each
isoform was conﬁrmed by western blot analysis with
anti-myc antibody (Figure 5B). Followed by RNA isola-
tion and RT-qPCR analysis, our data showed a 50%
decrease of FGF9 mRNA in cells overexpressing
p42
AUF1 (P<0.01), while the other AUF1 isoforms
(p37, p40 and p45) only had minor and non-signiﬁcant
effects on the FGF9 mRNA level (Figure 5C). As we
have demonstrated, AUF1 is involved in destabilization
of human FGF9 transcripts (Figure 4) and these data
suggested that p42
AUF1 has the ability to selectively
downregulate FGF9 expression by binding to 30-UTR
ARE and destabilizing the FGF9 transcripts.
AUF1 contributes to the regulation of PGE2-mediated
induction of FGF9 mRNA
We previously showed that PGE2 induces an acute and
transient increase of FGF9 mRNA in human primary
endometrial stromal cells (19). We hypothesized that
AUF1 is involved in the reduction of FGF9 mRNA in
stromal cells. To test this hypothesis, we knocked down
AUF1 by shRNA interference in primary endometrial
stromal cells. Western blot analysis revealed that the
AUF1 abundance was reduced by 60–90% in primary
stromal cells infected with AUF1 shRNA (Figure 6A).
We then determined whether knockdown of AUF1
affects FGF9 mRNA expression in non-stimulated cells
or cells exposed to PGE2. In agreement with previous
report, administration of 1mM PGE2 enhanced FGF9
mRNA by 3-fold; the level peaked at 4h and then
declined toward the basal level by 12h (P<0.001;
Figure 6B). Interestingly, AUF1 knockdown caused a
prolonged elevation of PGE2-induced FGF9 mRNA level
(P<0.001; Figure 6C). The FGF9 mRNA remained
elevated even at 24h after PGE2 treatment.
To reveal the mechanism underlying this regulation, we
measured the expression of AUF1 after PGE2 treatment in
whole-cell lysates, and found that PGE2 had no effect on
AUF1 expression in primary stromal cells (Figure 6D).
This suggested that other mechanisms, for example,
decreased amounts of cytoplasmic AUF1 (35) or phos-
phorylation of AUF1 proteins (36), are involved in the
regulation of PGE2-induced excess of FGF9 mRNA.
Further examination revealed that the levels of
AUF1 phosphorylation were not changed in non-
stimulated or PGE2-treated cells (Supplementary
Figure S2). Nevertheless, western blot data showed that
PGE2 signiﬁcantly reduce AUF1 amount in the cytoplas-
mic fraction while no effect was detected in the control
experiments (Figure 6E). Moreover, the time-dependent,
PGE2-mediated decline of cytoplasmic AUF1 showed
perfect correlation with the reduction of FGF9 mRNA
during the time course of this stimulation (Figure 6B
and E). These results demonstrated that AUF1, through
the change of its cellular distribution, plays a vital role in
controlling FGF9 mRNA level in PGE2-induced FGF9
transcription.
DISCUSSION
Fibroblast growth factor 9 plays numerous physiological
and pathological roles in many species (37). Considering
that FGF9 controls many vital functions in developmen-
tal, physiological and pathological processes, it is import-
ant to study the molecular mechanisms responsible for
Figure 5. AUF1 p42 isoform selectively downregulates FGF9 mRNA
expression. (A) Pull-down assay showing that p42
AUF1 is the major
isoform pulled down by biotin-labeled FGF9 ARE probe. Arrowhead
indicates the position of each AUF1 isoform. Note that the mutant is
markedly weaker than the wild type. Input and probe only indicate
positive and negative controls. (B) Western blots using anti-Myc
antibody showing the expression of indicated recombinant AUF1
proteins. HEK293 and pcDNA3.1 refer to cells without transfection
and cells transfected with empty vector, respectively. (C) Endogenous
FGF9 mRNA levels relative to control (pcDNA3.1) in cells
overexpressing the AUF1 isoforms p37, p40, p42 and p45. **P<0.01.
Nucleic Acids Research, 2010,Vol.38, No. 22 8067regulation of FGF9 gene expression. Previously, we
reported that PGE2, via its EP2 receptor-mediated signal-
ing pathway, transcriptionally upregulates FGF9 gene ex-
pression (19). Although the data provide valuable
information for understanding the regulation of FGF9
gene expression, it cannot answer the question of why
upregulation of FGF9 is transient. In this study, we
showed that a nonamer AU-rich element (AUUUAUU
UA) within the 30-UTR of the FGF9 transcript is
involved in rapid mRNA turnover. RNA–protein inter-
action and overexpression studies revealed that p42
AUF1
is the major isoform of the AUF1 protein family that
binds to FGF9 ARE to selectively regulate the levels of
FGF9 mRNA. Our data provided direct evidence to show
that AUF1 acts as a negative regulator for FGF9 expres-
sion post-transcriptionally. To our knowledge, this is the
ﬁrst report to demonstrate a post-transcriptional regula-
tion of FGF9 in any species. Our results provide the
molecular and cellular mechanism underlying the homeo-
stasis of FGF9 mRNA level in cells, an important balance
between the normal physiological function and abnormal
pathological process.
We determined that the half-life of FGF9 mRNA is
<20min, a typical characteristic of the mRNAs of
tightly regulated genes, which indicates that a post-
transcriptional regulatory mechanism exists to control
the lifespan of FGF9 mRNA. In addition, FGF9 is a
potent peptide growth factor that stimulates the
Figure 6. AUF1 knockdown sustains the PGE2-medicated induction of FGF9 mRNA in human primary endometrial stromal cells. (A) Western blots
showing successful AUF1 knockdown by AUF1-speciﬁc shRNA (B01, B03 and C03), but not the Luc control shRNA. The Null indicates cells
without shRNA treatment. (B) Western blots showing AUF1 protein expression in whole-cell lysates isolated from stromal cells after PGE2
treatment. (C) FGF9 mRNA levels measured at indicated times after PGE2 treatment in stromal cells. Ethanol (EtOH) was used as control treatment.
(D) Experiment similar to that shown in C, but with AUF1 knockdown by AUF1_B03 shRNA. All data are shown as mean±SEM of 4–6
independent experiments. *P<0.05; **P<0.01; ***P<0.001. (E) Western blots showing the distribution pattern of AUF1 protein in stromal cells
after PGE2 treatment. a-Tubulin and LaminA/C used as loading controls for proteins isolated from cytoplasmic and nuclear fractions, respectively.
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lium and stroma, prostate cancer cells and neuronal cells
(19). However, these effects must be controlled during a
short period of time to avoid overstimulation due to sus-
tained elevation of FGF9. PGE2 is a versatile eicosanoid
that regulates key responses in numerous physiological
and pathological processes (38). Results from the present
study showed that AUF1 is able to bind and reduce FGF9
mRNA to the basal level once it is transcriptionally
activated by PGE2. And AUF1 knockdown leads to main-
tained FGF9 mRNA levels after activation. These ﬁndings
indicate that AUF1 stops FGF9 signaling by destabilizing
FGF9 mRNA and thus reducing the amount of FGF9
protein synthesis. Taken together, these data also
suggest that AUF1 precisely regulates FGF9 signaling
by terminating the effect of environmental stimuli on
FGF9. This is a very important safeguarding system to
control FGF9 signaling within a precise time window or
at a certain developmental stage. Therefore, loss of this
control may prolong the effect of FGF9 and contribute to
disease processes. Reports of other AUF1 target mRNAs
from other groups are consistent with this theory. For
instance, alteration of the U-rich region in the 30-UTR
of Bcl-2 mRNA increases mRNA stability and contributes
to the overproduction of the anti-apoptotic Bcl-2 protein
that is responsible for the transformation of follicular
B-cell lymphoma (39,40). In addition, AUF1 knockout
mice display symptoms of severe endotoxic shock,
including vascular hemorrhage, intravascular coagulation
and high mortality, upon endotoxin challenge (41) sug-
gesting that the lack of this negative feedback system by
AUF1 indeed results in disease development and detri-
mental effects.
AUF1, the most extensively studied AU-rich element
binding protein, is a shuttle protein (42,43) with multiple
functions, such as DNA binding (44), RNA turnover (45)
and mRNA translation efﬁciency (46). The AUF1 family
contains four isoforms (p37, p40, p42 and p45) resulting
from alternative splicing. Different isoforms vary signiﬁ-
cantly in their cellular distribution and binding afﬁnity to
ARE-containing mRNA. It was suggested that relative
level, rather than the absolute amount of individual
AUF1isoform, determine the net mRNA stability of
ARE-containing transcripts (47). In this study, we
showed that the p40/p42 proteins are the predominant
isoforms in both HEK293 and human primary endomet-
rial stromal cells. In addition, we have shown that p42
isoform speciﬁcally suppresses FGF9 mRNA stability
compared with the other isoforms. Our results concur
with several lines of evidence that demonstrate certain
transcripts are under isoform-speciﬁc regulation by the
AUF1 family. For example, ectopic overexpression of
the p37 isoform selectively degrades ARE-containing
mRNA (42), the p45 isoform selectively binds to
estrogen receptor mRNA to upregulate gene expression
(48) and the p40 isoform selectively and positively regu-
lates interleukin (IL) 10 expression in monocytes (49).
Although it is known that different AUF1 isoforms have
different binding afﬁnity to speciﬁc mRNA 30-UTRs
(50,51), the detailed mechanism by which AUF1
isoforms selectively regulate FGF9 mRNA remains
unclear. In addition, a time-dependent decline in cytoplas-
mic AUF1 was observed along with the increase of FGF9
by PGE2 treatment, whereas the control experiments by
ethanol kept at relatively steady-state levels over the time
courses. The functional signiﬁcance of changing cellular
distribution of AUF1 still requires further investigation.
Nevertheless, similar changes in AUF1 decreasing cyto-
plasmic level have been associated with hydrogen
peroxide (H2O2)-induced p16 expression (35) and in
thyroid carcinoma progression (52).
The concept of RNA regulation has currently gained
much attention and attempts have been made to explain
the complex mechanisms of gene regulation at the post-
transcription level (53). The fate of transcripts with similar
functions may be under the same control mechanism, such
as the PUF RNA-binding protein family (53). The FGF
gene family members share a high degree of conservation
and are involved in diverse physiological events (37).
However, factors that regulate the expression of FGFs
remain largely elusive. Previous studies show that many
growth factors and signal traducers are ARE-containing
transcripts in the human genome [review see (54)]. Using
computational analysis (55), our data indicated that nine
members of the FGF family (FGF2, 4, 5, 7, 9, 14, 18, 19,
21 and 23) are all ARE-containing genes (Supplementary
Table S1). Although only FGF9 ARE is proved to be func-
tional and plays a vital role in FGF9 regulation in this
study, these data suggest that ARE-mediated decay is a
common pathway to control expression of FGFs. Further,
it also suggests that the ARE-mediated decay pathway is
another example of RNA regulon that coordinates several
physiological conditions through post-transcriptional
regulation.
In summary, we have identiﬁed a novel mechanism to
regulate FGF9 steady-state and stimulus-induced expres-
sion by AUF1-mediated mRNA decay. Considering that
FGF9 is a potent growth and survival factor, it is
not surprising that its expression is tightly controlled
by many factors such as transcription factors, microsatel-
lite motifs, and, as reported in this study, the RNA
destabilizing protein, AUF1. Our ﬁndings provide a new
point of view, that some diseases induced by
overexpression of peptide growth factors (such as FGF9)
might be due to loss-of-function of a negative regulator,
for example, an RNA destabilizing protein like AUF1.
Nevertheless, it is worth noting that we observed three
RNA–protein complexes in the UV cross-linking assay
using FGF9 ARE probe. It suggests other ARE-binding
proteins may also play some roles in regulation of FGF9
mRNA stability. Among all identiﬁed ARE-binding
proteins, both HuR (56) and KSRP (57) are known to
interact with AUF1 and coordinately regulate ARE-
containing mRNA stability. It is of interest to study
whether HuR or KSRP binds to FGF9 ARE and
control its expression in future investigations.
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